OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5
Francesco Fiorentino, Carola Castiello, Antonello Mai, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9580-9606
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Sirtuins, resveratrol and the intertwining cellular pathways connecting them
Anca Ungurianu, Anca Zanfirescu, Denisa Margină
Ageing Research Reviews (2023) Vol. 88, pp. 101936-101936
Closed Access | Times Cited: 50

SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
Chiara Lambona, Clemens Zwergel, Sérgio Valente, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1662-1689
Open Access | Times Cited: 17

Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 852-852
Open Access | Times Cited: 34

Synthesizing biomaterials in living organisms
Xiangyang Zhang, Junxia Wang, Ying Zhang, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 23, pp. 8126-8164
Closed Access | Times Cited: 27

Context-dependent role of SIRT3 in cancer
Jin Zhang, Jing Ye, Shiou Zhu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 173-190
Closed Access | Times Cited: 13

Sirtuins in kidney diseases: potential mechanism and therapeutic targets
Qi Jin, Fang Ma, Tong‐Tong Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Mitochondrial sirtuins: Energy dynamics and cancer metabolism
Hojun Lee, Haejin Yoon
Molecules and Cells (2024) Vol. 47, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 8

SIRT5 safeguards against primate skeletal muscle ageing via desuccinylation of TBK1
Qian Zhao, Ying Jing, Xiaoyu Jiang, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1

Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 7

Activation and inhibition of sirtuins: From bench to bedside
Francesco Fiorentino, Emanuele Fabbrizi, Antonello Mai, et al.
Medicinal Research Reviews (2024)
Open Access | Times Cited: 4

SIRT5 desuccinylating IDH2 to alleviate oxidative stress in bovine mammary epithelial cells induced by ammonia
Shikai Gao, Hanlin Yang, Jinru Dong, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139619-139619
Closed Access

SIRT5: a potential target for discovering bioactive natural products
Yuwei Xie, Ning Cai, Xiaohua Liu, et al.
Journal of Natural Medicines (2025)
Open Access

SIRT5 modulates mitochondria function via mitophagy and antioxidant mechanisms to facilitate oocyte maturation in mice
Jingjing Yan, Yanyu Wang, Zhanjun Shi, et al.
International Journal of Biological Macromolecules (2025), pp. 141488-141488
Closed Access

The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer
Cosmos Ifeanyi Onyiba, Christopher J. Scarlett, Judith Weidenhofer
Cancers (2022) Vol. 14, Iss. 20, pp. 5118-5118
Open Access | Times Cited: 21

Native mass spectrometry-directed drug discovery: Recent advances in investigating protein function and modulation
Francesco Fiorentino, Dante Rotili, Antonello Mai
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103548-103548
Open Access | Times Cited: 11

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors
Sultan Abda Neja, Wan Mohaiza Dashwood, Roderick H. Dashwood, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 396-396
Open Access | Times Cited: 4

Heterocycles‐Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
A. Russo Raucci, Carola Castiello, Antonello Mai, et al.
ChemMedChem (2024)
Open Access | Times Cited: 4

Structure–Activity Relationship Studies of 2,4,5-Trisubstituted Pyrimidine Derivatives Leading to the Identification of a Novel and Potent Sirtuin 5 Inhibitor against Sepsis-Associated Acute Kidney Injury
Luohe Mou, Lina Yang, Shuyan Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11517-11535
Closed Access | Times Cited: 9

Role of SIRT5 in cancer. Friend or Foe?
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 8

Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors
Jian Yao, Yudong Yin, Ho Jae Han, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115024-115024
Closed Access | Times Cited: 11

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives
María Paula Ceballos, Ariel D. Quiroga, Nicolás Francisco Palma
Biochemical Pharmacology (2023) Vol. 212, pp. 115573-115573
Closed Access | Times Cited: 6

Calponin 2 regulates ketogenesis to mitigate acute kidney injury
Yuan Gui, Zachary Palanza, Priya Gupta, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top